Zachary Katz, Chief Legal Officer and Head of Global Affairs at Grindr Inc. (NYSE:GRND), filed a Form 4 on August 19, 2026, reporting the sale of 10,172 shares of common stock on August 17, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Aaron Graeme Seyler, Chief Revenue Officer of Mitek Systems Inc, filed a Form 4 on August 19, 2026, disclosing the grant of restricted stock units and performance restricted stock units on August 17, 2026, as inducement awards tied to his acceptance of employment with …
Sophia Schwartz, Chief Legal Officer and Secretary of Nextdoor Holdings, Inc. (NYSE:NXDR), filed a Form 4 on August 19, 2026, disclosing a sale of Class A Common Stock on August 17, 2026, executed under a pre-established Rule 10b5-1 trading plan.
Christopher Griffith, Chief Operating Officer of American Coastal Insurance Corp (NASDAQ:ACIC), filed a Form 4 on August 19, 2026, disclosing the exercise of nonqualified stock options and the sale of common shares on August 17, 2026.
Julien Wetterwald, Chief Technology Officer of Wealthfront Corp, filed a Form 4 on August 19, 2026, disclosing the sale of 15,263 shares of common stock on August 17, 2026.
A Form 4 filed on August 19, 2026, reports that Ellen Barker, a director of Microchip Technology Incorporated (NASDAQ:MCHP), acquired common stock through the vesting of restricted stock units and received a new RSU grant on August 18, 2026.
TMC the metals company Inc. filed a current report on August 19, 2026, disclosing that the National Oceanic and Atmospheric Administration published in the Federal Register the consolidated application submitted by the company's subsidiary for an exploration license and commercial recovery permit for polymetallic …
BILL Holdings, Inc. filed a Current Report on Form 8-K with the SEC on August 19, 2026, disclosing the issuance of a press release and a planned conference call covering its financial results for the fourth quarter and fiscal year ended June 30, 2026.
Science Applications International Corporation filed an 8-K on August 19, 2026, disclosing that it entered into Amendment No. 6 to its Master Accounts Receivable Purchase Agreement with MUFG Bank, Ltd. on August 14, 2026.
Crinetics Pharmaceuticals, Inc. filed an 8-K on August 19, 2026, disclosing supplemental proxy disclosures related to its pending merger with Vertex Pharmaceuticals Incorporated, following shareholder complaints and demand letters alleging omissions in the previously filed proxy statement.